What birth control alternative can be considered for a 22-year-old on ethinyl estradiol (EE) 30mcg/levonorgestrel (LN) 150mcg complaining of mood swings, mild acne, and weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Birth Control Alternatives for a 22-Year-Old with Mood Swings, Acne, and Weight Gain

For a 22-year-old woman on ethinyl estradiol 30mcg/levonorgestrel 150mcg experiencing mood swings, mild acne, and weight gain, switching to a progestin-only method such as an IUD or a combined oral contraceptive with drospirenone would be most beneficial for addressing these specific side effects.

Understanding the Current Issues

The patient is experiencing three common side effects associated with hormonal contraceptives:

  1. Mood swings - Common with hormonal methods, particularly those containing levonorgestrel
  2. Mild acne - May be exacerbated by androgenic progestins like levonorgestrel
  3. Weight gain - Although most hormonal contraceptives are not consistently associated with weight gain except for depot medroxyprogesterone acetate 1

Recommended Alternatives

Option 1: Switch to a Combined Oral Contraceptive with Drospirenone

  • Drospirenone has antimineralocorticoid and antiandrogenic properties 2
  • Benefits for this patient:
    • Improved acne due to antiandrogenic effects 2
    • May reduce mood swings due to its unique properties
    • Less likely to cause water retention/bloating due to antimineralocorticoid effects
    • FDA-approved for moderate acne and PMDD 2

Option 2: Consider a Levonorgestrel IUD

  • Benefits:
    • Lower systemic hormone levels may reduce systemic side effects 3
    • High contraceptive efficacy (0.1-0.2% failure rate) 3
    • Less user-dependent than oral contraceptives 4
    • May lead to lighter periods or amenorrhea in 50% of users by 2 years 3

Option 3: Copper IUD (Non-hormonal)

  • Benefits:
    • Completely hormone-free, eliminating hormone-related side effects
    • Highly effective (0.8% failure rate) 3
    • Long-acting (up to 10 years) 3
  • Considerations:
    • May increase menstrual bleeding and cramping

Decision Algorithm

  1. If acne is the primary concern:

    • Choose a combined oral contraceptive with drospirenone, which has been shown to improve acne 2, 5
  2. If mood swings are the primary concern:

    • Consider drospirenone-containing COC or non-hormonal methods
  3. If weight gain/bloating is the primary concern:

    • Consider drospirenone-containing COC (antimineralocorticoid properties) or non-hormonal methods
  4. If the patient has difficulty with daily pill adherence:

    • Consider long-acting reversible contraceptives like IUDs or implants 4, 3

Important Considerations

  • Progestin-only pills are an option for women with contraindications to estrogen but have typical failure rates of 5-9% 3
  • The vaginal ring is another alternative with similar hormonal composition to COCs but different delivery method 4
  • The transdermal patch has similar efficacy to COCs but with increased estrogen exposure and potential increased risk of venous thromboembolism 4

Potential Pitfalls to Avoid

  • Adverse effects of hormonal contraceptives often diminish within 3-5 months of continued use, so reassurance may be all that's needed if symptoms are mild 1
  • Switching between different COCs with the same progestin type may not effectively address side effects 1
  • Weight gain is not consistently associated with most hormonal contraceptives except depot medroxyprogesterone acetate 1
  • Patient education about expected side effects is crucial to improve adherence and satisfaction 3

References

Research

Managing adverse effects of hormonal contraceptives.

American family physician, 2010

Research

Drospirenone/ethinyl estradiol.

Drugs of today (Barcelona, Spain : 1998), 2008

Guideline

Management of Intrauterine Device (IUD) Side Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.